Anuncia Medical
Scottsdale, US · Founded 2018 · Delaware corporation · 2 known investors
Anuncia Medical develops the ReFlow Ventricular System, an implantable device that lets patients or caregivers non-invasively flush a shunt catheter to help manage hydrocephalus, including in pediatric patients. The product is used by neurosurgeons and patients' families to reduce shunt revisions.
BiotechHealthtechMedical Devices
Founders & leadership
DB
Darryl BakerExecutive
EA
Elsa AbruzzoExecutive
Board
DD
ED
Edgar D JanottaBoard director
SR
Stanton RoweBoard director
SO
Stephen OesterleBoard director
PA
PJ AnandBoard director
GK
Ghassan KassabBoard director
RU
Richard UptonBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$17.7M disclosed across 3 rounds · 2021–2024
▶$13.9MraisedNov 2025 · 87 investors · BiotechnologyRule 506(b)
▶$13.9MraisedNov 2025 · 87 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stanton RoweDirector
- Darryl BakerExecutive Officer
- Elsa AbruzzoExecutive Officer, Director
- Stephen OesterleDirector
- PJ AnandDirector
- Ghassan KassabDirector
- Richard UptonDirector
- David DonabedianDirector
- Edgar D JanottaDirector
- Offering amount
- $16.4M
- Amount sold
- $13.9M
- Finders' fees
- $66.5K
- Proceeds to insiders
- $450K
- Placement agents
- U.S. Boston Capital Corporation
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedApr 2024 · 28 investors · BiotechnologyRule 506(b)
▶$3.4MraisedApr 2024 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ghassan KassabDirector
- Elsa AbruzzoExecutive Officer, Director
- PJ AnandDirector
- Stanton RoweDirector
- David DonabedianDirector
- Edgar D JanottaDirector
- Stephen OesterleDirector
- Richard UptonDirector
- Offering amount
- $4M
- Amount sold
- $3.4M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$427.5KraisedDec 2021 · 7 investors · BiotechnologyRule 506(b)
▶$427.5KraisedDec 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stanton RoweDirector
- Stephen OesterleDirector
- Edgar D JanottaDirector
- David DonabedianDirector
- Richard UptonDirector
- PJ AnandDirector
- Elsa AbruzzoExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $427.5K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapEncore Medical5 shared keywordsEncore Medical develops cardiovascular medical devices, with clinical work focused on patent foramen ovale (PFO) and related conditions such as migraine. It operates in the cardiovascular medical device sector.
Massdevice5 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
Cqmedical4 shared keywordsCQ Medical develops patient radiotherapy positioning products, including radiation immobilization masks and related devices used in cancer treatment and medical care. Formed in 2022 from the merger of legacy companies CIVCO RT and Qfix, it serves healthcare providers and patients in the radiotherapy field.
Bioworld4 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Innova Vascular4 shared keywordsInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
Rf Surgical4 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies competing with Anuncia Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Anuncia Medical do?
- Anuncia Medical develops the ReFlow Ventricular System, an implantable device that lets patients or caregivers non-invasively flush a shunt catheter to help manage hydrocephalus, including in pediatric patients. The product is used by neurosurgeons and patients' families to reduce shunt revisions.
- Who are Anuncia Medical's investors?
- Anuncia Medical's investors include Xcellerant Ventures, Longwood Fund.
- How much funding has Anuncia Medical raised?
- Anuncia Medical has disclosed $17.7M raised across 3 rounds.
- Where is Anuncia Medical headquartered?
- Anuncia Medical is headquartered in Scottsdale, US.